Viomedo

Viomedo operates a digital platform designed to bridge the gap between patients and medical research in the German-speaking region of Europe. Founded in Berlin in 2015, the company was established by Alexander Puschilov, Stefan Nietert, and Tim Seithe. The founding was inspired by Puschilov's own difficulties in finding participants for a clinical trial for a digital therapy he was developing. This personal experience highlighted a significant bottleneck in medical development, leading to the creation of Viomedo. Puschilov, a health economist from the London School of Economics, and Nietert, a business informatics specialist, combined their expertise to facilitate easier access to clinical studies for both patients and researchers.

The company's core business revolves around its online platform, which serves as a centralized, searchable database of clinical trials. For patients, the platform is free and simplifies the process of finding relevant studies by allowing them to search by illness and location. Viomedo translates complex scientific terminology into user-friendly language to ensure the information is accessible. Interested individuals can then directly contact the respective study centers through the platform. The business model generates revenue through collaborations with the sponsors of these clinical trials, which include pharmaceutical companies, research institutions, and scientists. This approach ensures the platform remains independent by featuring studies from both commercial and academic sources.

Viomedo's platform acts as a patient recruitment tool for the life sciences industry, helping to accelerate research timelines. It offers its clients—top pharmaceutical firms, biotech companies, and contract research organizations (CROs)—a suite of services for data-driven trial planning, site selection, and patient retention. The company leverages a distribution network that includes patient communities, health portals, and advocacy groups to reach potential trial participants. In 2018, Viomedo was acquired by Clariness, a Swiss company with a broader international focus in patient recruitment, a move intended to combine Clariness's global reach with Viomedo's localized integration in Germany and Austria. Following the acquisition, Viomedo continued to operate as a separate entity, expanding its services to Austria in 2019 with partners like Pfizer Austria and Boehringer Ingelheim.

Keywords: clinical trial recruitment, patient enrollment, medical research platform, digital health, patient access to clinical trials, German healthcare, Austrian healthcare, clinical study database, patient-centric trials, pharmaceutical services, CRO services, trial feasibility, site selection, patient retention, health-tech, life sciences, drug development acceleration, Clariness, Alexander Puschilov, Stefan Nietert